Cross-border reproductive care: an Ethics Committee opinion.
Cross-border reproductive care (CBRC) is a growing worldwide phenomenon, raising questions about why assisted reproductive technology (ART) patients travel abroad, what harms and benefits may result, and what duties health-care providers may have in advising and treating patients who travel for reproductive services. Cross-border care offers benefits and poses harms to ART stakeholders, including patients, offspring, providers, gamete donors, gestational carriers, and local populations in destination countries. This document replaces the previous document of the same name, last published in 2013 (Fertil Steril 2013;100:645-50).
American Society for Reproductive Medicine, Birmingham, Alabama.
D001291:Attitude of Health Personnel; D017041:Ethics Committees / Q000592:standards; D007722:Health Knowledge, Attitudes, Practice; D006297:Health Services Accessibility / Q000941:ethics* / Q000592:standards; D006801:Humans; D007246:Infertility / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D057193:Medical Tourism / Q000941:ethics*; D010353:Patient Education as Topic / Q000941:ethics; D061214:Patient Safety; D010819:Physician's Role; D027724:Reproductive Techniques, Assisted / Q000009:adverse effects / Q000941:ethics* / Q000592:standards; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome